The SLC11A2 gene helps your body absorb iron and move it into cells, especially cells that make red blood cells. If it does not work properly, your body may struggle to use iron, which can cause anemia with tiredness, weakness, and pale skin. Some people with harmful variants in the SLC11A2 gene also build up extra iron in organs despite having anemia.
What is a gene?
Genes are sections of DNA that hold instructions cells use to make molecules or regulate processes throughout the body. Some genes provide the information needed to make proteins, the functional parts of cells. Others mainly help direct when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
SLC11A2Gene function
What if the gene works
The SLC11A2 gene helps move iron into cells. This supports iron absorption from food and helps developing red blood cells make hemoglobin, the protein that carries oxygen.
Risk
What if the gene does not work
Variants in the SLC11A2 gene can reduce iron transport, causing microcytic anemia and sometimes liver iron buildup. Milder and more severe variants may affect when symptoms begin and how much anemia or iron overload develops.
Treatment
What does that mean for your treatment
No SLC11A2-specific treatment or drug-choice approach is currently established in clinical guidelines. Care is usually tailored to the person's anemia and iron balance rather than to the SLC11A2 variant itself. The SLC11A2 gene is also being studied as a possible drug target and biomarker in iron-related conditions, but this has not changed routine treatment.
Conditions associated with SLC11A2
Gene function
What if the gene works
Your body uses the SLC11A2 gene to move iron into cells where it can be used right away. This is a key part of how your body absorbs iron from food and delivers it to tissues. A steady iron supply supports red blood cells, muscles, and many everyday cell processes.
In the small intestine, the SLC11A2 gene helps move iron from digested food into the cells lining the gut. This is one of the main early steps in iron absorption in the small intestine.
Many cells take in iron in small packages after it travels through the blood. The SLC11A2 gene helps release that iron from internal compartments into the main part of the cell so it can be used.
By supplying cells with usable iron, the SLC11A2 gene supports the making of hemoglobin, the part of red blood cells that carries oxygen. It also helps tissues such as muscle get iron for myoglobin, which stores oxygen.
Iron is needed for many enzymes, which are proteins that help chemical reactions happen in the body. By moving iron into the right place, the SLC11A2 gene supports energy production and other routine cell tasks.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help account for normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC11A2 gene can change how the iron transporter is built, folded, or placed in the cell membrane, which helps explain how SLC11A2 variants affect iron transport. Some reduce transport only partly, while more severe variants can leave the protein unstable or unable to move iron at all. This loss of function can range from milder to stronger effects. In people with disease causing variants, stronger functional changes often go with earlier or more noticeable anemia.
How variants are linked to conditions
Pathogenic variants in the SLC11A2 gene cause a rare inherited condition called hypochromic microcytic anemia with iron overload. In people with SLC11A2-related hypochromic microcytic anemia with iron overload, anemia is usually present early in life, and extra iron may build up in the liver and other tissues. Finding a disease-causing variant alongside this pattern can confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widespread in the general population. Most have no direct effect on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC11A2, health risk is mainly linked to the specific gene change a person is born with, especially when both copies of the gene are affected. There is not enough evidence to say that diet, supplements, or other everyday factors meaningfully lower the chance of developing the genetic condition itself. Family history can change the chance of inheriting it.
Inheritance of SLC11A2 variants
Variants in the SLC11A2 gene are inherited in an autosomal recessive pattern for the well-established SLC11A2-related condition. This means a child usually inherits one changed copy from each parent, and parents who carry one variant typically do not have the condition themselves. With autosomal recessive SLC11A2 inheritance, when both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two working copies of the gene.
What does my SLC11A2 result mean for my family?
For SLC11A2, the main well-known family pattern is recessive, which means close relatives may be carriers even if they feel well. Brothers and sisters could also have the condition, while parents are often healthy carriers. Family members may want to review the result with their care team to understand what it could mean for them.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the SLC11A2 gene, doctors use genetic testing on a blood or saliva sample. SLC11A2 genetic testing reads the gene’s DNA code to look for changes, and some tests also check for missing or extra pieces. Results can show whether a variant is present and help clarify whether it may explain iron-related symptoms.
When should I consider getting a genetic test?
SLC11A2 genetic testing may be considered when someone has ongoing anemia that does not improve as expected, especially if iron builds up in the liver or similar problems run in the family. It can help clarify a rare inherited cause of trouble moving iron through the body.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it explains depends on the condition and the specific type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, moves, breaks down, or reacts to a drug, so the same treatment may work better for one person than another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medications. It studies gene-drug relationships to help explain why the same treatment can work differently in different people. For many drugs, genes influence both how strongly a medicine works and how the body handles it. This understanding can support more informed, more personalized treatment choices. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC11A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or new symptoms are best discussed with your doctor. Research on SLC11A2 has looked at how inherited changes might affect iron handling and response to iron treatment, but this is not used routinely to guide care.
History
The SLC11A2 gene entered medical research through studies of inherited anemia in laboratory animals, especially the Belgrade rat and the mk mouse. In the 1990s, researchers linked these longstanding models to the same iron transport pathway, which helped explain why the animals developed severe iron handling problems. Building on this early work, scientists cloned the human gene and described it under names such as DMT1 and NRAMP2 before the standardized name SLC11A2 became widely used. This was an important step in connecting animal findings with human blood and iron conditions. Over time, descriptions became more precise as gene mapping and sequencing confirmed the gene’s place in inherited iron related disease. That history helped move the field from observing unusual anemia patterns to identifying a specific genetic cause.